ARCHIVES

Advisors approve set-aside for alternative medicine “best case series.”

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies

September 18, 1998

Training Grants Are Back; IGMS Implements New Program, With Awards To Be Made In June

January 24, 1975

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995